Daewoong unveils stomatitis medication

Published: 2007-11-21 06:56:00

Updated: 2007-11-21 06:56:00

Daewoong has unveiled its supplemental agent (trade name: Impactamine, 12 tablets per pack) for relieving stomatitis, inflammation of the oral mucosa, from this month.

According to the company, it contains B1, B2, B3, B5, B6, B9, B12 and zinc and is effective in preventing the recurrence of st...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK